A New Indicator to Assess Stenosis Severity

Fractional Myocardial Mass to Assess Stenosis Severity

This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of stenosis physiological severity.

 

Researchers used CT angiography to study this new concept of myocardial mass subtended by a specific vessel, which could reduce anatomical-physiological mismatch.

 

The study included 463 patients with 724 lesions evaluated by multislice coronary computed tomography angiography and invasive coronary angiography with fractional flow reserve measurement (FFR).

 

Fractional myocardial mass was assessed based on arterial tree length and myocardial mass by CT.

 

FFR <0.80 was considered a functionally significant lesion and it was found in 39% of observed vessels. Fractional myocardial mass decreased consistently according to vessel caliber, which is obvious.

 

FFR <0.80 increased in direct proportion to fractional myocardial mass and inversely to angiographic minimal luminal diameter (p < 0.001).

 

Fractional myocardial mass and minimal luminal diameter showed good correlation with FFR (r=0.61) and resulted superior to stenosis diameter to predict FFR <0.80.

 

Optimal cutoff value for fractional myocardial mass/minimal luminal diameter was 29 g/mm with 75% sensitivity,   77% specificity and 77% diagnostic accuracy.

 

This relation could add information to the classical stenosis diameter to predict FFR<0.80.

 

 

Conclusion

The relation fractional myocardial mass / minimal luminal diameter could help discriminate functional compromise of vessels more accurately than anatomical stenosis. The concept of fractional myocardial mass could explain the discrepancy between anatomy and physiology.

 

Original Title: Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery.

Reference: Hyung Yoon Kim et al. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60.

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...